Indiana Life Sciences Summit to Highlight Innovation

Some of the nation’s leading life sciences executives, venture capitalists, entrepreneurs and researchers are headlining the 2012 Indiana Life Sciences Summit.

The all-star lineup includes leaders from Bloomberg, Cook Medical, Covance, Credit Suisse, Eli Lilly and Company, Endocyte, Harlan Laboratories, Marcadia Biotech, OrbiMed Ventures, OrthoWorx, Pfizer, Purdue University, Quaker Partners, Roche Diagnostics and Zimmer.
“It may say ‘Indiana’ in the name, but the summit has an incredible caliber of speakers and panelists, including some of the leading life sciences executives in the U.S. We have all of them in one place, discussing the current national/global issues and opportunities and how it affects Indiana and beyond. This is really a national level conference right here in our backyard,” stated Lori LeRoy, Public Relations and Marketing Director, BioCrossroads.

The summit kicks off Monday, October 22, 6:00 – 8:00 p.m., with the annual networking reception, this year hosted by Eli Lilly and Company and Cook Medical. Winners of the BioCrossroads New Venture Competition will be announced during this time.

John Lechleiter, Ph.D., President, Chairman and CEO of Eli Lilly and Company and Chairman, Pharmaceutical Research and Manufacturers of America, will present the morning keynote speech.

Also, three panel discussions are included in the summit, injecting an interactive element into the mix. “Getting several different perspectives from a number of life sciences thought leaders allows us to put a diverse group of executives from start-ups to large corporations to venture capital firms and academic institutions on the same stage. Their engaging dialogue provides interesting and valuable insight to our attendees,” stated LeRoy.

Panel topics and speakers include:
• Discovering Smarter Ways to Lead Innovation
Moderator: Brian Rye, Healthcare Financial Analyst, Bloomberg Government
David Broecker, President, Research Models & Services, Harlan Laboratories
Ron Ellis, Chief Executive Officer, Endocyte
Bill Ringo, former Senior Vice President, Pfizer and currently an adviser at Sofinnova Ventures
Deb Tanner, Executive Vice President and Group President, R&D Laboratories, Covance, Inc.

• The Opportunities and Challenges of Advancing Innovation in the Medical Device and Technology Sector
Market Overview and Moderator: David Floyd, Chief Executive Officer, OrthoWorx
Cheryl Blanchard, Ph.D., Senior Vice President, Chief Scientific Officer, Zimmer Holdings, Inc.
John Hertig, Executive Director, Alfred Mann Institute at Purdue University
Hans-Juergen Loyda, Director of Clinical Development and Education, Roche Diagnostics North America
Pete Yonkman, Executive Vice President, Strategic Business Units, Cook Medical

• Capitalizing in the Current Market: VCs and Entrepreneurs Talk Shop
Market Overview and Moderator: Jonathan Silverstein, General Partner, Orbimed
Adele Oliva, Partner, Quaker Partners
Kristin Sherman, Chief Financial Officer, AgeneBio / former CFO, Marcadia Biotech
Bernard Yancovich, Managing Partner, Credit Suisse

Sponsors for the conference include Faegre Baker Daniels, Bloomberg Government, Develop Indy/16 Tech, Indiana University, Miles Printing, Pricewaterhouse Coopers and VMS Biomarketing.

Register here.